Trial intelligence / Profile preview

Comparison of Dexamethasone and Celecoxib for Prophylaxis for Transcatheter Arterial Chemoembolization

KCT0003860Phase 4Recruiting

Sponsor
Chonnam National University Hwasun Hospital
Start
May 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexamethasone, celecoxib in hepatocellular carcinoma (HCC), sponsored by Chonnam National University Hwasun Hospital. Started May 2019; status: recruiting.

02

Drugs

dexamethasonecelecoxib
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on KCT0003860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call